Life Sciences 4.0 – the next step in evolution?

Life sciences companies must consider how to participate in emerging care platforms. Jürg Zürcher, Biotech/Medtech Leader at EY Switzerland, Germany and Austria, answers three questions. What does EY mean by the term Life Sciences 4.0? Increased customer expectations and rapid technological advances are disrupting the healthcare industry, causing power to shift across traditional stakeholder groups … More Life Sciences 4.0 – the next step in evolution?